Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07572214CompletedPrimary

Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)

NCT07140445Not Yet Recruiting

Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT

NCT06709690RecruitingPrimary

A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases

Showing all 3 trials

Research Network

Activity Timeline